Article info
Original Article
Dyloject, a Novel Injectable Diclofenac Formulation, Offers Greater Safety and Efficacy Than Voltarol for Postoperative Dental Pain
- Reprint requests: Daniel B. Carr, M.D., Chief Medical Officer, Javelin Pharmaceuticals, Inc. 125 Cambridge Park Drive, Cambridge, MA 02140. E-mail: dcarr{at}javelinpharmaceuticals.com
Citation
Dyloject, a Novel Injectable Diclofenac Formulation, Offers Greater Safety and Efficacy Than Voltarol for Postoperative Dental Pain
Publication history
- First published July 1, 2007.
Online issue publication
February 27, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2007 by the American Society of Regional Anesthesia and Pain Medicine